Abstract
Coronavirus disease-2019 (COVID-19) pandemic continues to threaten patients, societies, and economic and healthcare systems around the world. Like many other diseases, the host immune system determines the progress of COVID-19 and fatality. Modulation of inflammatory response and cytokine production using immunonutrition is a novel concept that has been applied to other diseases as well. Zinc, one of the anti-inflammatory and antioxidant micronutrient found in food with well-established role in immunity, is currently being used in some clinical trials against COVID-19. This review integrates the contemporary studies of role of zinc in antiviral immunity along with discussing its potential role against COVID-19, and ongoing COVID-19 clinical trials using zinc.
Original language | English |
---|---|
Number of pages | 11 |
Journal | Biological Trace Element Research |
DOIs | |
Publication status | E-pub ahead of print - Nov 22 2020 |
Keywords
- Clinical trials
- COVID-19
- Immunity
- Zinc
ASJC Scopus subject areas
- Endocrinology, Diabetes and Metabolism
- Biochemistry
- Clinical Biochemistry
- Biochemistry, medical
- Inorganic Chemistry